On-off-on luminescent pyrophosphate probe based on the use of Mn-doped ZnS quantum dots and using Eu(III) as a mediator

Synthesis of blue fluorescent molybdenum nanoclusters with novel terephthaldehyde-cysteine Schiff base for detection of pyrophosphate

In this work, terephthaldehyde-cysteine-molybdenum nanoclusters (TPA-Cys-MoNCs) were synthesized by using terephthaldehyde-cysteine (TPA-Cys) Schiff base as a novel ligand. The as-synthesized TPA-Cys-MoNCs showed blue fluorescence under UV lamp at 365 nm, displaying emission peak at 455 nm when excited at 340 nm. The fluorescent TPA-Cys-MoNCs are used as a probe for sensitive assay of pyrophosphate (PPi) via fluorescence quenching mechanism. The emission peak intensity of TPA-Cys-MoNCs at 455 nm exhibited a linear quenching with increasing amount of PPi. As a result, quantitative assay was developed for the detection of PPi (0.01-200 µM) with the detection limit of 0.9 nM. The developed probe was successfully demonstrated for the detection of PPi in biofluids (urine and plasma).

Fluorescent reversible regulation of cysteamine-capped ZnSe quantum dots successively induced by photoinduced electron transfer of herring sperm DNA and intercalation binding of ethidium bromide

A fluorescent reversible regulation was studied by fluorescence spectra, ultraviolet-visible spectra in the combination of molecular docking, which based on the photoinduced electron transfer(PET) from hsDNA (herring sperm DNA) to CA (cysteamine)-capped ZnSe QDs (quantum dots) and intercalation of ethidium bromide (EB) into hsDNA. It was proven that the QDs bound with the adding hsDNA by electrostatic force and formed 1:1 hsDNA-QDs complexes, leading to the PET from hsDNA to QDs, and consequently the fluorescence quenching of the QDs; with EB being added in the complex solution, it bound with hsDNA by intercalation interaction and caused hsDNA releasing from hsDNA-QDs complex with forming 2.5:1 EB-hsDNA complex, leading to the recovery of fluorescence, based on the greater binding constant (1.74 × 10⁶ L·mol^-1) of hsDNA with the embedded EB comparing to that of QDs with the captured hsDNA (4.25 × 10⁴ L·mol^-1). A good linear relationship existed between the fluorescence recovery yield and the EB concentrations under the range of 1.0-12.0 × 10^-6 mol·L^-1 with bare interference of related substances. This work provided some useful insights into the study of binding mechanism between DNAs with their intercalators and fluorescence bi-direction regulation, and showed great potential for the determination of trace EB.

Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening

Development of simple, convenient, and sensitive assay methods for pyrophosphatase (PPase) activity is of importance, for disease diagnosis and drug discovery. Herein, a simple, rapid, label-free, and sensitive fluorescence sensor for PPase activity assay is developed, using Cu²⁺ doping-induced quantum dot (QD) photoluminescence as a signal reporter. The Cu²⁺ doping of ZnSe QD can induce a dopant-dependent emission response, which will be inhibited after the premixing of Cu²⁺ with pyrophosphate (PPi), to form a Cu²⁺-PPi complex. Then, the hydrolysis of PPi into phosphate (Pi), specifically catalyzed by PPase, liberates the free Cu²⁺ to regain the QD doping for the fluorescence response, which is highly dependent on the PPase activity. The PPase can be sensitively and selectively assayed, with a detection limit of 0.1 mU/mL. The developed sensing strategy can be also employed for the PPase inhibitor screening. Thus, the current QD doping-based sensing strategy offers an efficient and promising avenue for Cu²⁺, PPi, or PPase-related target analysis, and might hold great potential for the further applications in the clinical disease diagnosis.